Latest filing published 13 Aug 2026 for BeOne Medicines Ltd., €2.2M.
Not enough history yet: 0 closed purchases, at least 2 are needed.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Oyler John Victor discloses dealings in BeOne Medicines Ltd. to SEC (Form 4). We count 200 filings; the first trade dates from 8 August 2018 and the latest from 12 August 2026.
On the open market, the record shows 7 purchases and 123 sales worth €54.9M. The totals exclude 100 filings filed without an amount. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. In 2026 alone, the filings show 1 purchase and 17 sales.
On 13 August 2026 came the latest disclosure, an open-market sale for €2.2M in BeOne Medicines Ltd. The most recent open-market purchase was published on 16 June 2026, 130 days ago. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 3 days. For comparison, the SEC allows two business days to file a Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
25 of 200 declarations